Vaccines very effective against hospital and ICU admissions, also for Delta variant
COVID-19 vaccines work well in preventing people from being admitted to hospital or ICU for COVID-19, according to a new analysis by RIVM.
Vaccination against COVID-19 reduces the transmission of the virus from one person to another. This is apparent from RIVM research using data from source and contact tracing by the Municipal Public Health Services (GGDs).
The RIVM vaccination update this week has been expanded to include three maps of the Netherlands. For the first time, it is now possible to see vaccination turnout by municipality for everyone aged 18 years and over.
541 new COVID-19 hospital admissions were reported last week, 23 fewer than in the week before, when 564 people with COVID-19 were admitted to hospital.
In the week from 24 to 30 March, 51,866 people in the Netherlands received a positive test result for COVID-19, an increase of 13% compared to the week before that.
Starting next week, eligible people who are not mobile enough to come to a vaccination site will be vaccinated at home. The GP will vaccinate them using the AstraZeneca vaccine. The vaccines will be delivered in phases per province.
Last year, the incidence of tuberculosis (TB) in the Netherlands fell sharply. The 17% drop is the largest in fifty years. In 2020, 623 cases were notified compared to 754 in 2019.
In the week from 17 to 23 March, 46,005 people received a positive test result for COVID-19, an increase of 16% compared to the week before that. The reproduction number continued to rise, from 1.06 on 1 March to 1.11 on 8 March.
The method developed by RIVM to assess whether waste treatment is sufficiently safe and sustainable, can contribute to the European ambitions for a safe and more circular economy.